Creating new catalysts to improve drug development
Development of Novel Biphilic Phosphorus Catalysts via Computational Modeling and Multidimensional Analysis
This study is exploring new ways to make medicines faster and better by using special phosphorus-based materials, which could help bring effective treatments to patients more quickly.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10885950 on NIH RePORTER |
What this research studies
This research focuses on developing innovative phosphorus-based catalysts that can enhance the synthesis of diverse pharmaceutical compounds. By using computational modeling and advanced analysis techniques, the project aims to better understand how these catalysts work and how their structures can be optimized for improved performance. This could lead to more efficient methods for creating new drugs, ultimately benefiting patients by speeding up the availability of effective treatments.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals who require new pharmaceutical treatments for various conditions.
Not a fit: Patients who are not seeking new medications or those with conditions that are not addressed by the types of drugs being developed may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more efficient drug development processes, resulting in new medications becoming available to patients more quickly.
How similar studies have performed: Previous research has shown promise in using alternative catalysts for drug development, indicating that this approach could lead to significant advancements.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Lavagnino, Marissa Nicole — Massachusetts Institute of Technology
- Study coordinator: Lavagnino, Marissa Nicole
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.